
On March 21, 2025, Sun Pharmaceutical Industries Ltd. witnessed a significant gain of 2.03%, closing at ₹1,786.50. The rally was accompanied by a noticeable increase in trading volume, far exceeding the 20-day average, signaling strong investor interest and potential accumulation in the stock.
Broad Index Inclusion Underscores Market Relevance
Sun Pharma is included in several major stock indices, demonstrating its broad market presence:
- NIFTY 50, NIFTY 500, NIFTY PHARMA, Nifty Healthcare Index
- Nifty100, Nifty200, Nifty LargeMidcap 250, Nifty India Manufacturing
- Nifty50 USD, Nifty50 Value 20, Nifty Alpha Low-Volatility 30, among others
This diversified index representation highlights the company’s cross-sectoral importance and widespread institutional exposure.
Sentiment Analysis: Bullish Momentum Strengthens
Investor sentiment has shifted significantly in recent days:
- March 17, 2025: Sentiment – Bullish | Closing Price – ₹1,704.30
- March 21, 2025: Sentiment – Very Bullish | Closing Price – ₹1,787.95
This upward trend aligns with increasing investor confidence, contributing to the recent price momentum.
Quarterly Financial Performance Snapshot
Revenue (in ₹ Cr):
- Dec 2023: 12,380.70
- Mar 2024: 11,982.90
- Jun 2024: 12,652.75
- Sep 2024: 13,291.39
- Dec 2024: 13,675.46
Net Profit (in ₹ Cr):
- Dec 2023: 2,568.03
- Mar 2024: 2,666.59
- Jun 2024: 2,871.25
- Sep 2024: 3,030.67
- Dec 2024: 2,917.54
Earnings Per Share (EPS):
- Dec 2023: ₹10.50
- Mar 2024: ₹11.10
- Jun 2024: ₹11.80
- Sep 2024: ₹12.70
- Dec 2024: ₹12.10
Annual Financial Growth
From FY2020 to FY2024, Sun Pharma reported significant growth:
- Revenue: ₹32,837.50 Cr → ₹48,496.85 Cr
- Net Profit: ₹4,186.79 Cr → ₹9,648.44 Cr
- EPS: ₹15.70 → ₹39.90
Key Financial Ratios (as of March 2024)
- Basic EPS: ₹39.90
- Book Value/Share: ₹279.69
- Return on Equity (ROE): 15.04%
- Debt-to-Equity Ratio: 0.04
- Price-to-Earnings (P/E): 40.62
- Price-to-Book (P/B): 6.11
- Price-to-Sales (P/S): 8.02
Read More: Best Budget JioHotstar Plans Under ₹250 to Stream IPL 2025 on Mobile: Jio, Airtel & Vi Compared